| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |